TherapeuticsMD Statistics
Total Valuation
TherapeuticsMD has a market cap or net worth of $11.53 million. The enterprise value is $13.65 million.
Important Dates
The next estimated earnings date is Friday, May 9, 2025, after market close.
Earnings Date | May 9, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TherapeuticsMD has 11.57 million shares outstanding. The number of shares has increased by 10.45% in one year.
Current Share Class | 11.57M |
Shares Outstanding | 11.57M |
Shares Change (YoY) | +10.45% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 2.02% |
Owned by Institutions (%) | 14.71% |
Float | 9.51M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 6.52 |
Forward PS | n/a |
PB Ratio | 0.42 |
P/TBV Ratio | 0.50 |
P/FCF Ratio | 15.75 |
P/OCF Ratio | 15.75 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 7.75 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 18.64 |
Financial Position
The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.26.
Current Ratio | 2.37 |
Quick Ratio | 1.67 |
Debt / Equity | 0.26 |
Debt / EBITDA | n/a |
Debt / FCF | 9.80 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -8.16% and return on invested capital (ROIC) is -6.08%.
Return on Equity (ROE) | -8.16% |
Return on Assets (ROA) | -5.31% |
Return on Invested Capital (ROIC) | -6.08% |
Return on Capital Employed (ROCE) | -10.38% |
Revenue Per Employee | $1.76M |
Profits Per Employee | -$2.18M |
Employee Count | 1 |
Asset Turnover | 0.04 |
Inventory Turnover | n/a |
Taxes
Income Tax | -31,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.44% in the last 52 weeks. The beta is 0.95, so TherapeuticsMD's price volatility has been similar to the market average.
Beta (5Y) | 0.95 |
52-Week Price Change | -46.44% |
50-Day Moving Average | 0.93 |
200-Day Moving Average | 1.36 |
Relative Strength Index (RSI) | 54.82 |
Average Volume (20 Days) | 42,959 |
Short Selling Information
The latest short interest is 169,192, so 1.46% of the outstanding shares have been sold short.
Short Interest | 169,192 |
Short Previous Month | 170,162 |
Short % of Shares Out | 1.46% |
Short % of Float | 1.78% |
Short Ratio (days to cover) | 2.31 |
Income Statement
In the last 12 months, TherapeuticsMD had revenue of $1.76 million and -$2.18 million in losses. Loss per share was -$0.19.
Revenue | 1.76M |
Gross Profit | 1.76M |
Operating Income | -3.49M |
Pretax Income | -6.13M |
Net Income | -2.18M |
EBITDA | -2.98M |
EBIT | -3.49M |
Loss Per Share | -$0.19 |
Full Income Statement Balance Sheet
The company has $5.06 million in cash and $7.18 million in debt, giving a net cash position of -$2.12 million or -$0.18 per share.
Cash & Cash Equivalents | 5.06M |
Total Debt | 7.18M |
Net Cash | -2.12M |
Net Cash Per Share | -$0.18 |
Equity (Book Value) | 27.37M |
Book Value Per Share | 2.37 |
Working Capital | 7.09M |
Full Balance Sheet Cash Flow
Operating Cash Flow | 732,000 |
Capital Expenditures | n/a |
Free Cash Flow | 732,000 |
FCF Per Share | $0.06 |
Full Cash Flow Statement Margins
Gross margin is 100.00%, with operating and profit margins of -198.30% and -123.85%.
Gross Margin | 100.00% |
Operating Margin | -198.30% |
Pretax Margin | -133.05% |
Profit Margin | -123.85% |
EBITDA Margin | -169.39% |
EBIT Margin | -198.30% |
FCF Margin | 41.57% |